Pulmonary & Nasal Drug Delivery
Issue No #57
April 30th, 2015
Inside the magazine
Dr Paul Kippax
INVESTIGATING THE DE-AGGLOMERATION PROFILES OF DPI FORMULATIONS
Paul Kippax from Malvern Instruments, Srinivas Ravindra Babu Behara, David Morton, Ian Larson and Peter Stewart from Monash University describe the use of laser diffraction to analyse dry powder behaviour.
Dr Tim Noakes
MDI PROPELLANTS – IS THE POPULARITY OF HFA 227EA SET TO GROW?
Tim Noakes predicts a rise in demand for HFA 227ea – a less common MDI propellant than the better-known HFA 134a.
IMPROVING THE REALISM AND RELEVANCE OF MOUTH-THROAT MODELS FOR INHALED PRODUCT TESTING
Mark Copley provides some background on mouth-throat models for OIP testing.
COMPANY SHOWCASE: NEMERA
In 2014, the healthcare business formerly known as Rexam Healthcare Devices became Nemera. This name change followed the May 2, 2014 acquisition by Montagu Private Equity.
THE ADVANTAGES OF DESIGNING HIGH-RESISTANCE SWIRL CHAMBERS
David Harris taps into a powerful combination of detailed anatomical and functional understanding of the human respiratory system, pulmonary drug delivery technology and formulation expertise.
Dr Anna Fureby
PULMONARY DELIVERY OF ANTIMICROBIAL PEPTIDES
Anna Fureby, Ulla Elofsson and Per Gerde discuss the serious problem of antibiotic resistance and the potential role of antimicrobial peptides in the treatment of resistant bacterial strains.
Dr Kirsten Markgraf
POLYMERS WITH IMPROVED TRIBOLOGY
Kirsten Markgraf and Wendy Johnson review the performance of various polyoxymethylene acetal copolymer grades, and introduce two new grades optimised for sliding applications.
HUMAN-CENTRED DESIGN AT THE HEART OF A SUCCESSFUL PRODUCT DEVELOPMENT PROCESS
Bill Welch and Jeremy Odegard provide an insight into how the company’s human centred design approach fits into its integrated product development process.
PROFITABLE ASSEMBLY AUTOMATION THROUGH USE OF STANDARDISED MACHINE PLATFORMS
Reiner Zeidler describes the company’s modular TEAMED production system, and how it meets the inhaler device industry’s needs – from early development applications right through to commercial-scale manufacture.
This website uses functional cookies (but not advertising cookies). View our
Privacy & Cookies Policy